Literature DB >> 7659502

A novel human c-sis mRNA species is transcribed from a promoter in c-sis intron 1 and contains the code for an alternative PDGF B-like protein.

R P Dirks1, C Onnekink, H J Jansen, A de Jong, H P Bloemers.   

Abstract

The human platelet-derived growth factor (PDGF) B chain precursor is usually translated from a 3.5 kb c-sis/PDGF B gene transcript. The first exon of the c-sis/gene contains the code for the signal peptide of the PDGF B chain precursor, preceded by a 1 kb long untranslated sequence with potent translation inhibitory activity. In this paper we show that a novel 2.6 kb c-sis mRNA present in the human choriocarcinoma cell line JEG-3 initiates at an alternative exon 1, which we refer to as exon 1a. The 90 bp long exon 1a is located in the center of the first intron of the gene. It coincides with a very pronounced DNase-I-hypersensitive site and is preceded by a functional promoter. Of the three ATG codons present in exon 1a, the third one perfectly matches the criteria of a consensus start codon. It initiates an open reading frame that is continuous with the code for the PDGF B chain precursor but lacks the code for a signal peptide. We conclude that this novel 2.6 kb c-sis mRNA species lacks the strong translation inhibitory potential of the regular exon 1 and contains the code for a PDGF B-like protein that may be targeted to the cell nucleus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7659502      PMCID: PMC307116          DOI: 10.1093/nar/23.15.2815

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  53 in total

1.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

2.  Transformation of NIH 3T3 cells by a human c-sis cDNA clone.

Authors:  M F Clarke; E Westin; D Schmidt; S F Josephs; L Ratner; F Wong-Staal; R C Gallo; M S Reitz
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

3.  Nucleotide sequence analysis identifies the human c-sis proto-oncogene as a structural gene for platelet-derived growth factor.

Authors:  I M Chiu; E P Reddy; D Givol; K C Robbins; S R Tronick; S A Aaronson
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

4.  Chromosomal mapping of the simian sarcoma virus onc gene analogue in human cells.

Authors:  D C Swan; O W McBride; K C Robbins; D A Keithley; E P Reddy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

5.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Human-proto-oncogene nucleotide sequences corresponding to the transforming region of simian sarcoma virus.

Authors:  S F Josephs; C Guo; L Ratner; F Wong-Staal
Journal:  Science       Date:  1984-02-03       Impact factor: 47.728

8.  Dual mode of signal transduction by externally added acidic fibroblast growth factor.

Authors:  A Wiedłocha; P O Falnes; I H Madshus; K Sandvig; S Olsnes
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

9.  Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor.

Authors:  R F Doolittle; M W Hunkapiller; L E Hood; S G Devare; K C Robbins; S A Aaronson; H N Antoniades
Journal:  Science       Date:  1983-07-15       Impact factor: 47.728

10.  Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus.

Authors:  M D Waterfield; G T Scrace; N Whittle; P Stroobant; A Johnsson; A Wasteson; B Westermark; C H Heldin; J S Huang; T F Deuel
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.